-
Je něco špatně v tomto záznamu ?
Management of Paediatric Ulcerative Colitis, Part 1: Ambulatory Care-An Evidence-based Guideline From European Crohn's and Colitis Organization and European Society of Paediatric Gastroenterology, Hepatology and Nutrition
D. Turner, FM. Ruemmele, E. Orlanski-Meyer, AM. Griffiths, JM. de Carpi, J. Bronsky, G. Veres, M. Aloi, C. Strisciuglio, CP. Braegger, A. Assa, C. Romano, S. Hussey, M. Stanton, M. Pakarinen, L. de Ridder, K. Katsanos, N. Croft, V. Navas-López,...
Jazyk angličtina Země Spojené státy americké
Typ dokumentu konsensus - konference, časopisecké články, směrnice pro lékařskou praxi
Grantová podpora
G0800675
Medical Research Council - United Kingdom
- MeSH
- ambulantní péče normy MeSH
- dítě MeSH
- fyziologie výživy dětí MeSH
- lidé MeSH
- společnosti lékařské MeSH
- ulcerózní kolitida diagnóza terapie MeSH
- Check Tag
- dítě MeSH
- lidé MeSH
- mužské pohlaví MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- konsensus - konference MeSH
- směrnice pro lékařskou praxi MeSH
- Geografické názvy
- Evropa MeSH
BACKGROUND: The contemporary management of ambulatory ulcerative colitis (UC) continues to be challenging with ∼20% of children needing a colectomy within childhood years. We thus aimed to standardize daily treatment of pediatric UC and inflammatory bowel diseases (IBD)-unclassified through detailed recommendations and practice points. METHODS: These guidelines are a joint effort of the European Crohn's and Colitis Organization (ECCO) and the Paediatric IBD Porto group of European Society of Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN). An extensive literature search with subsequent evidence appraisal using robust methodology was performed before 2 face-to-face meetings. All 40 included recommendations and 86 practice points were endorsed by 43 experts in Paediatric IBD with at least an 88% consensus rate. RESULTS: These guidelines discuss how to optimize the use of mesalamine (including topical), systemic and locally active steroids, thiopurines and, for more severe disease, biologics. The use of other emerging therapies and the role of surgery are also covered. Algorithms are provided to aid therapeutic decision-making based on clinical assessment and the Paediatric UC Activity Index (PUCAI). Advice on contemporary therapeutic targets incorporating the use of calprotectin and the role of therapeutic drug monitoring are presented, as well as other management considerations around pouchitis, extraintestinal manifestations, nutrition, growth, psychology, and transition. A brief section on disease classification using the PIBD-classes criteria and IBD-unclassified is also part of these guidelines. CONCLUSIONS: These guidelines provide a guide to clinicians managing children with UC and IBD-unclassified management to provide modern management strategies while maintaining vigilance around appropriate outcomes and safety issues.
1st Department of Pediatrics Semmelweis University Budapest Hungary
Barts and the London School of Medicine Queen Mary University of London London UK
BC Children's Hospital University of British Columbia Vancouver BC Canada
Child Life and Health University of Edinburgh Edinburgh UK
Department of Paediatrics University Hospital Motol Prague Czech Republic
Erasmus MC Sophia Children's Hospital Rotterdam The Netherlands
Helsinki University Children's Hospital Department of Pediatric Surgery Helsinki Finland
Hospital Sant Joan de Déu Barcelona Spain
Pediatric Department University of Messina Messina Italy
Pediatric Gastroenterology and Liver Unit Sapienza University of Rome Rome Italy
Pediatric Gastroenterology and Nutrition Unit Hospital Materno IBIMA Málaga Spain
School of Medical Sciences Ioannina University of Ioannina Ioannina Greece
Shaare Zedek Medical Center The Hebrew University of Jerusalem Jerusalem Israel
Southampton Children's Hospital Southampton UK
The Hospital for Sick Children University of Toronto Toronto Canada
The Royal Hospital for Children Glasgow UK
Université Paris Descartes Sorbonne Paris Cité APHP Hôpital Necker Enfants Malades Paris France
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc19045346
- 003
- CZ-PrNML
- 005
- 20200115091446.0
- 007
- ta
- 008
- 200109s2018 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1097/MPG.0000000000002035 $2 doi
- 035 __
- $a (PubMed)30044357
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Turner, Dan $u Shaare Zedek Medical Center, The Hebrew University of Jerusalem, Jerusalem, Israel.
- 245 10
- $a Management of Paediatric Ulcerative Colitis, Part 1: Ambulatory Care-An Evidence-based Guideline From European Crohn's and Colitis Organization and European Society of Paediatric Gastroenterology, Hepatology and Nutrition / $c D. Turner, FM. Ruemmele, E. Orlanski-Meyer, AM. Griffiths, JM. de Carpi, J. Bronsky, G. Veres, M. Aloi, C. Strisciuglio, CP. Braegger, A. Assa, C. Romano, S. Hussey, M. Stanton, M. Pakarinen, L. de Ridder, K. Katsanos, N. Croft, V. Navas-López, DC. Wilson, S. Lawrence, RK. Russell,
- 520 9_
- $a BACKGROUND: The contemporary management of ambulatory ulcerative colitis (UC) continues to be challenging with ∼20% of children needing a colectomy within childhood years. We thus aimed to standardize daily treatment of pediatric UC and inflammatory bowel diseases (IBD)-unclassified through detailed recommendations and practice points. METHODS: These guidelines are a joint effort of the European Crohn's and Colitis Organization (ECCO) and the Paediatric IBD Porto group of European Society of Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN). An extensive literature search with subsequent evidence appraisal using robust methodology was performed before 2 face-to-face meetings. All 40 included recommendations and 86 practice points were endorsed by 43 experts in Paediatric IBD with at least an 88% consensus rate. RESULTS: These guidelines discuss how to optimize the use of mesalamine (including topical), systemic and locally active steroids, thiopurines and, for more severe disease, biologics. The use of other emerging therapies and the role of surgery are also covered. Algorithms are provided to aid therapeutic decision-making based on clinical assessment and the Paediatric UC Activity Index (PUCAI). Advice on contemporary therapeutic targets incorporating the use of calprotectin and the role of therapeutic drug monitoring are presented, as well as other management considerations around pouchitis, extraintestinal manifestations, nutrition, growth, psychology, and transition. A brief section on disease classification using the PIBD-classes criteria and IBD-unclassified is also part of these guidelines. CONCLUSIONS: These guidelines provide a guide to clinicians managing children with UC and IBD-unclassified management to provide modern management strategies while maintaining vigilance around appropriate outcomes and safety issues.
- 650 _2
- $a ambulantní péče $x normy $7 D000553
- 650 _2
- $a dítě $7 D002648
- 650 _2
- $a fyziologie výživy dětí $7 D002664
- 650 _2
- $a ulcerózní kolitida $x diagnóza $x terapie $7 D003093
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a společnosti lékařské $7 D012955
- 651 _2
- $a Evropa $7 D005060
- 655 _2
- $a konsensus - konference $7 D016446
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a směrnice pro lékařskou praxi $7 D017065
- 700 1_
- $a Ruemmele, Frank M $u Université Paris Descartes, Sorbonne Paris Cité, APHP, Hôpital Necker Enfants Malades, Paris, France.
- 700 1_
- $a Orlanski-Meyer, Esther $u Shaare Zedek Medical Center, The Hebrew University of Jerusalem, Jerusalem, Israel.
- 700 1_
- $a Griffiths, Anne M $u The Hospital for Sick Children, University of Toronto, Toronto, Canada.
- 700 1_
- $a de Carpi, Javier Martin $u Hospital Sant Joan de Déu, Barcelona, Spain.
- 700 1_
- $a Bronsky, Jiri $u Department of Paediatrics, University Hospital Motol, Prague, Czech Republic.
- 700 1_
- $a Veres, Gabor $u 1st Department of Pediatrics, Semmelweis University, Budapest, Hungary.
- 700 1_
- $a Aloi, Marina $u Pediatric Gastroenterology and Liver Unit, Sapienza University of Rome, Rome, Italy.
- 700 1_
- $a Strisciuglio, Caterina $u Department of Woman, Child and General and Specialistic Surgery, University of Campania "Luigi Vanvitelli," Napoli, Italy.
- 700 1_
- $a Braegger, Christian P $u University Children's Hospital, Zurich, Switzerland.
- 700 1_
- $a Assa, Amit $u Schneider Children's Hospital, Petach Tikva, Affiliated to the Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
- 700 1_
- $a Romano, Claudio $u Pediatric Department, University of Messina, Messina, Italy.
- 700 1_
- $a Hussey, Séamus $u National Children's Research Centre, Royal College of Surgeons of Ireland and University College Dublin, Dublin, Ireland.
- 700 1_
- $a Stanton, Michael $u Southampton Children's Hospital, Southampton, UK.
- 700 1_
- $a Pakarinen, Mikko $u Helsinki University Children's Hospital, Department of Pediatric Surgery, Helsinki, Finland.
- 700 1_
- $a de Ridder, Lissy $u Erasmus MC-Sophia Children's Hospital, Rotterdam, The Netherlands.
- 700 1_
- $a Katsanos, Konstantinos $u School of Medical Sciences Ioannina, University of Ioannina, Ioannina, Greece.
- 700 1_
- $a Croft, Nick $u Barts and the London School of Medicine, Queen Mary University of London, London, UK.
- 700 1_
- $a Navas-López, Victor $u Pediatric Gastroenterology and Nutrition Unit. Hospital Materno, IBIMA, Málaga, Spain.
- 700 1_
- $a Wilson, David C $u Child Life and Health, University of Edinburgh, Edinburgh, UK.
- 700 1_
- $a Lawrence, Sally $u BC Children's Hospital, University of British Columbia, Vancouver, BC, Canada.
- 700 1_
- $a Russell, Richard K $u The Royal Hospital for Children, Glasgow, UK.
- 773 0_
- $w MED00010080 $t Journal of pediatric gastroenterology and nutrition $x 1536-4801 $g Roč. 67, č. 2 (2018), s. 257-291
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/30044357 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20200109 $b ABA008
- 991 __
- $a 20200115091820 $b ABA008
- 999 __
- $a ok $b bmc $g 1483615 $s 1084019
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2018 $b 67 $c 2 $d 257-291 $e - $i 1536-4801 $m Journal of pediatric gastroenterology and nutrition $n J Pediatr Gastroenterol Nutr $x MED00010080
- GRA __
- $a G0800675 $p Medical Research Council $2 United Kingdom
- LZP __
- $a Pubmed-20200109